Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nabil E Omar

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Clinical Case Reports|July 22, 2022
Cardiac Metastases from Choroidal MelanomaAmmar Madani, Nabil E Omar, Ghulam Mustafa, et al.
Cancer Control : Journal of the Moffitt Cancer Center|November 26, 2025
Extent and Mitigation of Financial Toxicity of Immune Checkpoint Inhibitors for the Treatment of Advanced Hepatocellular CarcinomaNabil E Omar, Hazem Elewa, Kareem A El-Fass, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|November 14, 2019
Perceptions and expectations of health care providers towards clinical pharmacy services at a tertiary cancer centre in QatarNabil E Omar, Shereen Elazzazy, Oraib Abdallah, et al.
Medicine|December 29, 2020
Tumor lysis syndrome in chronic lymphocytic leukemia: conventional treatment versus novel agents: A protocol for systematic review and meta-analysisNancy Kassem, Ahmed A Ghazy, Mohammad Abu-Tineh, et al.
Frontiers in Oncology|January 8, 2024
Tyrosine Kinase Inhibitors in pediatric chronic myeloid leukemia: a focused review of clinical trialsFateen Ata, Maria Benkhadra, Rola Ghasoub, et al.
Cancer Control : Journal of the Moffitt Cancer Center|March 10, 2026
Effect of RAS Pathway Gene Mutations on Survival in Myelodysplastic Syndrome: A Systematic Review and Meta-AnalysisYasmin Eslalakawi, Mohamed Omar Saad, Amin S Sanosi, et al.
Clinical Case Reports|March 26, 2021
Fatal temozolomide induced aplastic anemia in a female with Glioblastoma multiforme : A case report and literature reviewFateen Ata, Safna Farsana Akkam Veettil, Mohammed Gaber, et al.
Frontiers in Immunology|November 16, 2020
Diagnosis and Management of Hematological Adverse Events Induced by Immune Checkpoint Inhibitors: A Systematic ReviewNabil E Omar, Kareem A El-Fass, Abdelrahman I Abushouk, et al.
Cancer Immunology, Immunotherapy : CII|October 18, 2020
Tuberculosis following programmed cell death receptor-1 (PD-1) inhibitor in a patient with non-small cell lung cancer. Case report and literature reviewAasir M Suliman, Shaza A Bek, Mohamed S Elkhatim, et al.
Clinical Medicine Insights. Oncology|October 17, 2024
Real-World Data Presenting the Descriptive Analysis of the Use of Tyrosine Kinase Inhibitors (TKIs) Among Metastatic Non-Small-Cell Lung Cancer (mNSCLC) Patients in Qatar: A Nationwide Retrospective Cohort StudyRawan Dawoud, Harman Saman, Kakil Rasul, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Clinical Case Reports|July 22, 2022
Cardiac Metastases from Choroidal MelanomaAmmar Madani, Nabil E Omar, Ghulam Mustafa, et al.
Cancer Control : Journal of the Moffitt Cancer Center|November 26, 2025
Extent and Mitigation of Financial Toxicity of Immune Checkpoint Inhibitors for the Treatment of Advanced Hepatocellular CarcinomaNabil E Omar, Hazem Elewa, Kareem A El-Fass, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|November 14, 2019
Perceptions and expectations of health care providers towards clinical pharmacy services at a tertiary cancer centre in QatarNabil E Omar, Shereen Elazzazy, Oraib Abdallah, et al.
Medicine|December 29, 2020
Tumor lysis syndrome in chronic lymphocytic leukemia: conventional treatment versus novel agents: A protocol for systematic review and meta-analysisNancy Kassem, Ahmed A Ghazy, Mohammad Abu-Tineh, et al.
Frontiers in Oncology|January 8, 2024
Tyrosine Kinase Inhibitors in pediatric chronic myeloid leukemia: a focused review of clinical trialsFateen Ata, Maria Benkhadra, Rola Ghasoub, et al.
Cancer Control : Journal of the Moffitt Cancer Center|March 10, 2026
Effect of RAS Pathway Gene Mutations on Survival in Myelodysplastic Syndrome: A Systematic Review and Meta-AnalysisYasmin Eslalakawi, Mohamed Omar Saad, Amin S Sanosi, et al.
Clinical Case Reports|March 26, 2021
Fatal temozolomide induced aplastic anemia in a female with Glioblastoma multiforme : A case report and literature reviewFateen Ata, Safna Farsana Akkam Veettil, Mohammed Gaber, et al.
Frontiers in Immunology|November 16, 2020
Diagnosis and Management of Hematological Adverse Events Induced by Immune Checkpoint Inhibitors: A Systematic ReviewNabil E Omar, Kareem A El-Fass, Abdelrahman I Abushouk, et al.
Cancer Immunology, Immunotherapy : CII|October 18, 2020
Tuberculosis following programmed cell death receptor-1 (PD-1) inhibitor in a patient with non-small cell lung cancer. Case report and literature reviewAasir M Suliman, Shaza A Bek, Mohamed S Elkhatim, et al.
Clinical Medicine Insights. Oncology|October 17, 2024
Real-World Data Presenting the Descriptive Analysis of the Use of Tyrosine Kinase Inhibitors (TKIs) Among Metastatic Non-Small-Cell Lung Cancer (mNSCLC) Patients in Qatar: A Nationwide Retrospective Cohort StudyRawan Dawoud, Harman Saman, Kakil Rasul, et al.
Pageof 3